
Dr McCann on the Importance of Reaching Consensus on the Role of Vepdegestrant in ER+ Breast Cancer
"Trying to figure out what we're going to do with this data [also] includes the fact that patients [may] have a preference [of receiving an oral treatment vs fulvestrant]. Our next round of trials is [focused on] combination therapies, and so …